While the immunomodulatory mechanisms of Gal-1 have been clearly elucidated, its direct role on carcinogenesis has not been studied in much detail even for CRC in which a positive correlation with a worsening disease status has been reported (39, 40). This evidence concerns the gene LGALS1 and colorectal carcinoma.